Peyer James
SEC Form 4 insider trading activity
Peyer James has filed 3 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 1, 2026.
On the most recent filing, Peyer James is listed as 10% Owner at Sensei Biotherapeutics, Inc. Inside the rolling window, Peyer James reported no open-market purchases and 5 open-market sales totaling $788K in SNSE. The largest disclosed transaction in the window is a sale of 25,000 SNSE shares on Jun 1, 2026, worth $501K.
Companies traded
Other insiders at SNSE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$788K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Peyer James made?
Peyer James has filed 3 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Peyer James trade?
Peyer James has filed SEC Form 4 disclosures for 1 company, including SNSE.
When was Peyer James's most recent SEC Form 4 filing?
Peyer James's most recent SEC Form 4 filing on Tracefour is dated Jun 1, 2026.
What is Peyer James's total buy and sell value in the current window?
Inside the rolling retention window, Peyer James bought $0 and sold $788K based on SEC Form 4 filings.
What was Peyer James's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 SNSE shares on 2026-06-01, worth $501K, per SEC Form 4 filings.